Financials

  • Market Capitalization 13.83 M
  • Employee 18
  • Founded 2017
  • CEO N/A
  • Website vyometx.com
  • Headquarter Delaware, United States
  • FIGI BBG0036S6JY0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.71
Rapporto prezzo/fatturato
23.26

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4565
TCRX
TScan Therapeutics, Inc. - Common Stock
0.22 USD-8.33%-18.52%-29.03%-89.62%13.97 M USD
4570
ALLR
Allarity Therapeutics, Inc. - Common stock
0.87 USD+1.16%-14.71%-25.00%-42.38%13.84 M USD
4574
TVRD
Tvardi Therapeutics, Inc. - Common Stock
1.04 USD-1.89%-3.70%-43.17%-71.11%13.87 M USD
4576
NCEL
NewcelX Ltd. - Ordinary Shares
2.84 USD-2.07%-6.58%-15.22%-44.09%13.62 M USD